Regulatory confusion, inappropriate headlines, and scientific transparency are just three of the big issues affecting the probiotics sector, says the executive director of the International Probiotics Association.
The US Food and Drug Administration is developing a next-generation toolbox for analyzing live microbial products, including DNA microarrays, metagenomic sequencing and analysis, and a whole genome database development.
Experts from the US FDA, EFSA, Food Standards Australia New Zealand, and Anvisa will provide regulatory insights about global probiotic regulations at the 2016 IPA World Congress + Probiota Americas.
The understanding of what happens within the human digestive system has always been hampered by the inability to observe that system in action, leave alone the imperfect understanding of one of the major components of the system, the gut microbiome. ...
The immediate future of the probiotics space is clouded by regulatory uncertainty but is buoyed by new science and technology, speakers at the recent Probiota Americas event said.
The dawn of inexpensive, rapid genetic sequencing has opened up new avenues for explaining the connection of the gut to the brain. With this new understanding of the precise makeup of the gut microbiome, medical science, and by extension the probiotic...
Evidence continues to mount that the gut microbiome affects gut health in a number of ways, one of which appears to be by inducing the nervous system to send signals to the brain via the vagus nerve and other pathways. Can the makeup of this microbial...
A study detailed at the Probiota Americas gathering in San Diego showed how supplementation of Bacillus coagulans combined with protein decreases muscle damage and boosts recovery post exercise. And it’s the first study that directly links probiotics...
How do probiotic researchers and suppliers best communicate with customers? And what should they be trying to tell them, anyway? Having a clear picture of what gut and blood parameters a dietary intervention is meant to affect and having a clear mechanism...
According to one prominent executive, for the probiotics industry, the fallout from the NYAG affair should be fairly straightforward: Make sure you know how to do what you’re supposed to do in the first place. Identify and count, it’s as simple as that.
Emerging methodologies and technologies such as the Smart Pill, non-invasive molecular methods using exfoliated epithelial cells, and uBiome, need further consideration and evaluation from key stakeholders to identify their validity as markers of digestive...
Using probiotics and prebiotics to alter the gut microbiota and influence the gut-brain axis may open up new ways of influencing neuropsychological conditions, says a new review.
San Diego will host the first ever Probiota Americas in June 2015, which will bring together eminent scientists and business leaders from the pre & probiotic and microbiota focused nutrition industries of North and South America.
